Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

XTL Biopharmaceuticals Ltd. - American Depositary Shares (NQ:XTLB)

0.8721 -0.1979 (-18.50%)
Streaming Delayed Price Updated: 9:37 AM EST, Jan 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about XTL Biopharmaceuticals Ltd. - American Depositary Shares

News headline image
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Names Mr. Noam Band as its New Chief Executive Officer
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Entered Definitive Agreement to Acquire The Social Proxy
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL To Aquire The Social Proxy
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
News headline image
XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
From XTL Biopharmaceuticals Ltd.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.